Skip to content

Drug interactions

Glimepiride-pioglitazone + Pitavastatin

Severity: Minor

Glimepiride-pioglitazone and Pitavastatin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

The legacy concern is that pioglitazone raises pitavastatin exposure through OATP1B1 inhibition and increases myopathy risk. Pioglitazone is not an established clinically relevant OATP1B1 inhibitor, and no meaningful interaction is documented.

What this interaction means in plain words

Glimepiride-pioglitazone and Pitavastatin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Glimepiride-pioglitazone belongs to Endocrine; Pitavastatin belongs to Cardiovascular.

Evidence level: Low

Why it happens

Theoretical OATP1B1 inhibition by pioglitazone; not established clinically.

What to do

No dose adjustment is needed; counsel patients to report unexplained muscle pain or weakness.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Glimepiride-pioglitazone and Pitavastatin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Glimepiride-pioglitazone with Pitavastatin?

MediHelp rates the interaction as minor. Glimepiride-pioglitazone and Pitavastatin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. The legacy concern is that pioglitazone raises pitavastatin exposure through OATP1B1 inhibition and increases myopathy risk. Pioglitazone is not an established clinically relevant OATP1B1 inhibitor, and no meaningful interaction is documented.

How serious is the interaction between Glimepiride-pioglitazone and Pitavastatin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is needed; counsel patients to report unexplained muscle pain or weakness.

What other medicines interact with Glimepiride-pioglitazone?

MediHelp also lists interactions of Glimepiride-pioglitazone with, for example, Fluconazole, Gemfibrozil, Insulin aspart. The full list is on the Glimepiride-pioglitazone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in